Two Landmark Indian Studies, One Common Thread: Organomation Evaporation Technology

India's research ecosystem is undergoing a well-documented expansion, with the country's laboratory equipment market projected to grow from roughly USD 3.5 billion in 2024 to more than USD 8 billion by 2035 at a compound annual growth rate near 7.9%. A parallel estimate puts the market at USD 1.17 billion in 2025, expanding at a 5.6% CAGR as diagnostics, pharmaceutical R&D, and academic research activity accelerate nationwide. Behind those macro numbers are thousands of individual laboratories choosing the instruments that make rigorous, publishable science possible — and a growing number of them are reaching for Organomation's N-EVAP and MULTIVAP nitrogen evaporators for a deceptively simple but critical step: sample concentration.

Two recent, peer-reviewed studies from leading Indian research institutions illustrate this trend clearly. One, from the Central Laboratory for Stem Cell Research and Translational Medicine at Deccan College of Medical Sciences in Hyderabad, used a MULTIVAP sample evaporator to prepare drug-metabolism samples for HPLC analysis in a groundbreaking bioengineered liver model. The other, from the CSIR-Central Food Technological Research Institute (CSIR-CFTRI) in Mysuru, relied on an N-EVAP evaporation system to dry carotenoid extracts during the development of a novel probiotic Spirulina yogurt. Together, they show how Organomation's sample-prep platforms are quietly underpinning diverse frontiers of Indian science — from regenerative medicine to functional food innovation.

Bioengineered Humanized Livers: A Hyderabad Team's Drug-Testing Breakthrough

Researchers at Deccan College of Medical Sciences, led by Sandeep Kumar Vishwakarma and Aleem Ahmed Khan, developed a three-dimensional humanized liver model by repopulating acellularized rat liver scaffolds with human hepatic progenitor cells — an approach designed to overcome the major shortcomings of animal models and 2D cell cultures in preclinical drug testing. Drug testing failure rates remain a persistent industry problem, with roughly 90% of candidate drugs failing due to unpredictable adverse events that go undetected in preclinical phases, and an average cost of about USD 2 billion to bring a single drug to market.

To validate their model, the team dosed the bioengineered livers with six well-established cytochrome P-450 (CYP) probe substrates — phenacetin, diclofenac, S-mephenytoin, dextromethorphan, nifedipine, and testosterone — to measure real-world drug metabolism. After a two-hour metabolism window, the reaction was quenched and the supernatant dried using steam of nitrogen with the help of a MULTIVAP evaporator set at 40°C before the residue was reconstituted for HPLC injection. This nitrogen-blowdown drying step was essential to concentrate the drug metabolites into a form suitable for the tertiary-gradient HPLC system used to quantify substrate depletion.

The results were striking: the bioengineered humanized liver metabolized several CYP substrates significantly better than conventional 2D cultures, with depletion rates exceeding 20% for dextromethorphan, 25% for mephenytoin, and 10% each for diclofenac and phenacetin. The study's authors positioned this humanized 3D model as a superior alternative to animal testing and existing "organs-on-chip" technology, since it preserves the liver's natural vascular architecture, extracellular matrix, and human-specific metabolic enzyme activity — factors that directly affect the accuracy of pharmacokinetic and toxicity predictions ahead of costly human clinical trials.

A Carotenoid-Enriched Spirulina Yogurt from CSIR-CFTRI, Mysuru

In a very different application, food scientists at CSIR-CFTRI's Plant Cell Biotechnology Department — Pravin Patel, Hitesh Jethani, Vikas S. Chauhan, and colleagues — set out to solve a longstanding problem in functional food development: incorporating Spirulina platensis microalgae into dairy products without the odor, flavor, and texture drawbacks associated with dried Spirulina powder. Using fresh, wet Spirulina biomass homogenized directly into toned milk at 200±10 bar, the team created a probiotic yogurt that not only avoided the sensory pitfalls of dried biomass but also delivered measurable functional benefits.

The Spirulina-supplemented yogurt increased Lactobacillus acidophilus counts by 29.56%, cut fermentation time by 20%, and achieved a total probiotic count of 1.2 × 10⁷ CFU/mL — well above India's Food Safety and Standards Authority of India (FSSAI) minimum requirement of one million CFU/g for probiotic products. Critically for a country where vitamin A deficiency remains a recognized public health challenge among preschool children, the enriched yogurt delivered meaningful pro-vitamin A content: a 100-gram serving of the optimized 7% (w/w) formulation met 27.3% of the Indian Council of Medical Research's recommended daily allowance of β-carotene for adults and 40.93% for children.

To precisely quantify that β-carotene content, the researchers turned to HPLC analysis of freeze-dried yogurt extracts. As the methodology states, "the extracts were dried by nitrogen evaporator (N-EVAP 111, Organomation, U.S.A.) and 10 μL of pigment extract was injected into HPLC system" equipped with a photodiode array detector for pigment identification. This nitrogen-drying step ensured the carotenoid extract was free of solvent interference before chromatographic separation — a routine but indispensable part of accurate pigment quantification.

Why Nitrogen Evaporation Matter Across Such Different Fields

What links a stem-cell laboratory in Hyderabad to a food technology institute in Mysuru is a shared analytical bottleneck: before any HPLC system can deliver a clean, quantifiable peak, solvent must be gently and completely removed without degrading heat- or light-sensitive analytes like cytochrome P-450 metabolites or carotenoids. Organomation's N-EVAP and MULTIVAP platforms address this using parallel nitrogen blowdown across an adjustable, multi-position sample manifold, with independent flow control at each position and heated water or dry-block baths ranging up to 120°C. That combination of throughput, gentleness, and precision explains why these instruments turn up across such disparate applications — tissue engineering, food chemistry, environmental testing, and beyond.

The Broader Growth Story in Indian Analytical Chemistry

These two studies are not isolated data points; they reflect a structural shift in India's research capacity. CSIR-CFTRI alone operates NABL-accredited chemical and biological testing laboratories under ISO 17025:2017 certification and runs active doctoral research programs feeding a steady pipeline of publications requiring rigorous instrumental analysis. Nationally, India's laboratory and scientific equipment market is expected to keep climbing on the back of rising pharmaceutical and biotech R&D investment, an expanding healthcare diagnostics sector, and tightening regulatory quality-control requirements. Even adjacent segments like laboratory information management systems (LIMS) are projected to grow at an 8.7% CAGR through 2031, a proxy for the broader digitization and scale-up of Indian lab operations.

As Indian institutions publish more internationally visible, peer-reviewed research — appearing in journals like World Journal of Hepatology and Journal of Food Science and Technology — the instruments cited in their methods sections become part of the global record of how that research was conducted. For laboratories evaluating sample-preparation equipment, the appearance of N-EVAP and MULTIVAP systems in such varied, high-impact Indian studies signals a level of trust in the technology's reliability, precision, and adaptability across disciplines ranging from hepatology to food carotenoid analysis.

What This Means for Labs Considering Nitrogen Evaporation Systems

Laboratories in India evaluating sample concentration equipment for HPLC, LC-MS, or GC workflows can draw several practical lessons from these case studies. Both research teams needed a system that could handle small, heat-sensitive extract volumes without degrading target analytes, offer independent gas-flow control across samples processed in parallel, and integrate cleanly into downstream chromatographic workflows. The MULTIVAP line, in particular, has been engineered for larger sample batches — models range from 9 to 100 positions, with water-bath versions reaching 100°C and dry-block versions reaching 120°C — while requiring notably lower nitrogen consumption than comparable competitor systems.

For institutions balancing tight consumable budgets against growing sample throughput — a familiar constraint at CSIR laboratories and medical college research centers alike — that efficiency matters as much as raw capacity. As more Indian labs publish methods sections citing N-EVAP and MULTIVAP systems, the instruments are becoming an increasingly familiar fixture in the country's expanding analytical chemistry infrastructure.